For help on how to get the results you want, see our search tips.
29 results
-
List item
Referral: Seresto and its associated name Foresto
imidacloprid and flumethrin, associated names: Foresto, Article 13
Status: European Commission final decision, opinion/position date: 15/02/2018, EC decision date: 25/05/2018, Last updated: 10/07/2018 -
List item
Referral: Resflor solution injectable and associated names
florfenicol, flunixin, Article 13
Status: European Commission final decision, opinion/position date: 07/10/2014, EC decision date: 05/12/2014, Last updated: 09/01/2015 -
List item
Referral: Vasotop P
ramipril, Article 13
Status: European Commission final decision, opinion/position date: 08/12/2009, EC decision date: 27/04/2010, Last updated: 14/08/2014 -
List item
Referral: Cobactan DC and its associated names
cefquinome, associated names: Cephaguard DC, Cobactan DC intramam Susp. Ad us. Vet, Cobactan DC suspension intramammaire, Article 13
Status: European Commission final decision, opinion/position date: 20/07/2006, EC decision date: 13/10/2006, Last updated: 12/08/2014 -
List item
Referral: Cydectin TriclaMox
moxidectin / triclabendazole, Article 13
Status: European Commission final decision, opinion/position date: 16/07/2013, EC decision date: 25/09/2013, Last updated: 18/10/2013 -
List item
Referral: Soludox
doxycycline hyclate, Article 13
Status: European Commission final decision, opinion/position date: 12/06/2013, EC decision date: 12/08/2013, Last updated: 24/09/2013 -
List item
Referral: Ethinylestradiol-Drospirenone 24+4
ethinylestradiol / drospirenone, associated names: Yaz 24+4, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 19/04/2012, EC decision date: 06/07/2012, Last updated: 11/01/2013 -
List item
Referral: Yaz 24+4
ethinylestradiol / drospirenone, associated names: Ethinylestradiol-Drospirenone 24+4, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 19/04/2012, EC decision date: 03/07/2012, Last updated: 11/01/2013 -
List item
Referral: Valproat Ratiopharm Chrono
valproic acid / valproate, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 25/05/2010, EC decision date: 26/05/2010, Last updated: 23/07/2012 -
List item
Referral: Genotropin
somatropin, associated names: Genotonorm, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 24/06/2010, EC decision date: 02/09/2010, Last updated: 26/04/2011 -
List item
Referral: Extraneal
icodextrin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 22/10/2009, EC decision date: 20/01/2010, Last updated: 27/10/2009 -
List item
Referral: Arcoxia
etoricoxib, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 26/06/2008, EC decision date: 09/09/2008, Last updated: 21/11/2008 -
List item
Referral: Actira
moxifloxacin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 20/03/2008, EC decision date: 14/07/2008, Last updated: 13/10/2008 -
List item
Referral: Avelox
moxifloxacin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 20/03/2008, EC decision date: 14/07/2008, Last updated: 13/10/2008 -
List item
Referral: Octegra
moxifloxacin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 20/03/2008, EC decision date: 14/07/2008, Last updated: 13/10/2008 -
List item
Referral: Belanette
Drospirenone + Ethinylestradiol, Article 5(11) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 14/12/2007, EC decision date: 17/06/2008, Last updated: 03/07/2008 -
List item
Referral: Yasminelle
Drospirenone + Ethinylestradiol, Article 5(11) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 14/12/2007, EC decision date: 17/06/2008, Last updated: 03/07/2008 -
List item
Referral: Sortis
atorvastatin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 24/03/2006, EC decision date: 22/05/2006, Last updated: 09/12/2006 -
List item
Referral: Prozac
Fluoxetine, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 01/06/2006, EC decision date: 21/08/2006, Last updated: 05/09/2006 -
List item
Referral: Coversyl
Perindopril, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 27/07/2005, EC decision date: 07/11/2005, Last updated: 23/12/2005 -
List item
Referral: Laurina
Desogestrel/ethinlestradiol, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 25/09/2003, EC decision date: 05/02/2004, Last updated: 01/03/2004 -
List item
Referral: Lisinopril Biochemie
Lisinopril, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 24/07/2003, EC decision date: 23/02/2004, Last updated: 01/09/2003 -
List item
Referral: Genotropin
Somatropin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 20/03/2003, EC decision date: 26/06/2003, Last updated: 29/08/2003 -
List item
Referral: Norditropin
Somatropin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 20/03/2003, Last updated: 29/08/2003 -
List item
Referral: Salmeterol and Fluticasone Propionate
Salmeterol and fluticasone, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 24/01/2003, EC decision date: 21/05/2003, Last updated: 31/07/2003